178 related articles for article (PubMed ID: 30203148)
21. EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.
Ye P; Li F; Wei Y; Zhang Y; Cui J; Dai R; Chen H; Xie J; Cai P
Sci Rep; 2022 Jul; 12(1):12894. PubMed ID: 35902718
[TBL] [Abstract][Full Text] [Related]
22. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
23. Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH.
Buhmeida A; Assidi M; Al-Maghrabi J; Dallol A; Sibiany A; Al-Ahwal M; Chaudhary A; Abuzenadah A; Al-Qahtani M
Cancer Invest; 2018 Feb; 36(2):129-140. PubMed ID: 29504811
[TBL] [Abstract][Full Text] [Related]
24. Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer.
Saito T; Nakanishi H; Mochizuki Y; Ito S; Ito Y; Misawa K; Yatabe Y; Yamamichi K; Kondo E
Gastric Cancer; 2015 Oct; 18(4):711-9. PubMed ID: 25173363
[TBL] [Abstract][Full Text] [Related]
25. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
Wei Q; Sheng L; Shui Y; Hu Q; Nordgren H; Carlsson J
Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
[TBL] [Abstract][Full Text] [Related]
26. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y
Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318
[TBL] [Abstract][Full Text] [Related]
27. HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
Lédel F; Hallström M; Ragnhammar P; Öhrling K; Edler D
Eur J Cancer; 2014 Feb; 50(3):656-62. PubMed ID: 24300455
[TBL] [Abstract][Full Text] [Related]
28. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
[TBL] [Abstract][Full Text] [Related]
29. Limited effect of lymph node status on the metastatic pattern in colorectal cancer.
Knijn N; van Erning FN; Overbeek LI; Punt CJ; Lemmens VE; Hugen N; Nagtegaal ID
Oncotarget; 2016 May; 7(22):31699-707. PubMed ID: 27145371
[TBL] [Abstract][Full Text] [Related]
30. Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
Schweiger T; Nikolowsky C; Starlinger P; Traxler D; Zimmermann M; Birner P; Hegedüs B; Dome B; Bergmann M; Mildner M; Klepetko W; Hoetzenecker K; Ankersmit HJ
PLoS One; 2015; 10(3):e0120724. PubMed ID: 25793600
[TBL] [Abstract][Full Text] [Related]
31. Increased lymphangiogenesis in lung metastases from colorectal cancer is associated with early lymph node recurrence and decreased overall survival.
Schweiger T; Nikolowsky C; Graeter T; Seebacher G; Laufer J; Glueck O; Glogner C; Birner P; Lang G; Klepetko W; Ankersmit HJ; Hoetzenecker K
Clin Exp Metastasis; 2016 Feb; 33(2):133-41. PubMed ID: 26498830
[TBL] [Abstract][Full Text] [Related]
32. HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value.
Seo AN; Kwak Y; Kim WH; Kim DW; Kang SB; Choe G; Lee HS
Virchows Arch; 2015 Jun; 466(6):645-54. PubMed ID: 25739551
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.
Gervaz P; Rubbia-Brandt L; Andres A; Majno P; Roth A; Morel P; Mentha G
Ann Surg Oncol; 2010 Oct; 17(10):2714-9. PubMed ID: 20405223
[TBL] [Abstract][Full Text] [Related]
34. Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.
Rossi S; Basso M; Strippoli A; Dadduzio V; Cerchiaro E; Barile R; D'Argento E; Cassano A; Schinzari G; Barone C
Clin Breast Cancer; 2015 Oct; 15(5):307-12. PubMed ID: 25922284
[TBL] [Abstract][Full Text] [Related]
35. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
[TBL] [Abstract][Full Text] [Related]
36. Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease.
Tanaka R; Sasajima Y; Tsuda H; Namikawa K; Takahashi A; Tsutsumida A; Fujisawa Y; Fujimoto M; Yamazaki N
Clin Exp Metastasis; 2016 Oct; 33(7):687-97. PubMed ID: 27289366
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric examination of p53 protein in primary tumors and metastases to the liver and lymph nodes of colorectal cancer.
Kimura O; Sugamura K; Kijima T; Makino M; Shirai H; Tatebe S; Ito H; Kaibara N
Dis Colon Rectum; 1996 Dec; 39(12):1428-33. PubMed ID: 8969671
[TBL] [Abstract][Full Text] [Related]
38. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers.
Kleist B; Meurer T; Poetsch M
Tumour Biol; 2017 Mar; 39(3):1010428317692246. PubMed ID: 28345467
[TBL] [Abstract][Full Text] [Related]
40. Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival.
Sawai H; Yasuda A; Ochi N; Ma J; Matsuo Y; Wakasugi T; Takahashi H; Funahashi H; Sato M; Takeyama H
BMC Gastroenterol; 2008 Nov; 8():56. PubMed ID: 19036165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
